Related Experiment Video

Updated: Sep 7, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.6K

STAT3 in medulloblastoma: a key transcriptional regulator and potential therapeutic target

Anwar Zaiter1, Zahraa F Audi1, Fatima Shawraba1

  • 1Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Hadath, Beirut, Lebanon.

Molecular Biology Reports
|June 18, 2022
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) drives pediatric medulloblastoma growth and resistance. Inhibiting STAT3 offers a promising therapeutic strategy for this common childhood brain tumor.

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Medulloblastoma is the most common malignant pediatric brain tumor, often lacking effective treatments.
  • Signal transducer and activator of transcription 3 (STAT3) is crucial in medulloblastoma initiation and progression.
  • STAT3 signaling pathways are implicated in tumor growth, survival, drug resistance, and recurrence.

Purpose of the Study:

  • To review the role of STAT3 in medulloblastoma pathogenesis.
  • To discuss STAT3 inhibition as a potential therapeutic strategy.

Main Methods:

  • Literature review focusing on STAT3's role in medulloblastoma.
  • Analysis of molecular mechanisms involving STAT3 signaling.

Main Results:

  • STAT3 is pivotal in medulloblastoma proliferation, survival, angiogenesis, and immunosuppression.
  • STAT3 contributes to tumor maintenance, drug resistance, and recurrence.
  • STAT3 inhibition demonstrates potential as a therapeutic approach.

Conclusions:

  • STAT3 is a key driver of medulloblastoma.
  • Targeting STAT3 represents a promising therapeutic avenue for medulloblastoma.
Keywords:
InhibitorsMedulloblastomaSignal transducer and activator of transcription 3Signaling pathway

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K